A methacholine challenge test is a breathing test that measures how sensitive your airways are. It’s primarily used to help diagnose asthma when standard lung function tests come back normal. During the test, you inhale increasing doses of a substance called methacholine, which causes your airways to narrow slightly. If your airways react strongly at low doses, it suggests the kind of airway hyperresponsiveness that’s characteristic of asthma.
How the Test Works
Methacholine mimics a natural chemical messenger in your body called acetylcholine. When inhaled, it binds to specific receptors on the smooth muscle lining your airways, causing that muscle to contract and the airways to narrow. Everyone’s airways will eventually narrow in response to methacholine if the dose is high enough. The question is how much it takes.
In people with asthma, the airways are “twitchy.” They overreact to stimuli that wouldn’t bother healthy lungs. This overreaction, called airway hyperresponsiveness, means their airways narrow at much lower doses of methacholine. The test exploits this difference to separate people with asthma from people without it. Importantly, the response isn’t just about the muscle itself. The starting size of your airways and the structural support around them also influence how much narrowing occurs at each dose.
What Happens During the Test
The test follows a structured, step-by-step protocol. You start by doing a baseline spirometry test, which involves blowing out as hard and fast as you can into a machine that measures your lung function. This gives your technician a reference point.
Next, you inhale a plain saline solution (the control) through a nebulizer. After that, you inhale methacholine in progressively higher concentrations. The standard dosing scheme starts very low, around 0.03 mg/mL, and increases through a series of steps up to 16 mg/mL. A shortened version of the protocol uses fewer steps: 0.06, 0.25, 1, 4, and 16 mg/mL. Each dose is spaced 5 minutes apart to keep the cumulative effect consistent.
After each dose, you perform spirometry again, typically at 30 and 90 seconds after inhaling, so the technician can track how your lung function is changing. The key measurement is your FEV1, which is the volume of air you can force out of your lungs in one second. If your FEV1 drops by 20% or more from your baseline, the test is considered positive and stops immediately. If you get through the highest dose without that 20% drop, the test is negative.
The whole process generally takes 30 to 60 minutes, depending on how many dose steps are needed.
What a Positive or Negative Result Means
The test result is reported as a PC20, the concentration of methacholine that caused your FEV1 to fall by 20%. A lower PC20 means your airways are more reactive. Generally, a PC20 below 4 mg/mL is considered a clear positive result consistent with asthma. Values between 4 and 16 mg/mL fall into a borderline or mildly reactive range, and a PC20 above 16 mg/mL is considered normal.
The real strength of this test is its ability to rule out asthma rather than confirm it. A negative result is extremely reliable. In one large study of nearly 500 people, the negative predictive value was 97.7%, meaning that if your test comes back negative, there’s less than a 3% chance you actually have asthma. However, a positive result is less definitive. The test’s specificity is relatively low, around 39% in some clinical settings, because other conditions like allergies, respiratory infections, and chronic obstructive pulmonary disease can also cause airway hyperresponsiveness. A positive result tells your doctor that your airways are reactive, but additional clinical context is needed to confirm an asthma diagnosis.
Preparing for the Test
Several things can interfere with the accuracy of your results, so preparation matters. You’ll typically be asked to stop taking certain medications beforehand. Short-acting bronchodilators (rescue inhalers) are usually withheld for 6 to 8 hours, while long-acting bronchodilators need to be stopped 24 to 48 hours before. Antihistamines and leukotriene blockers may also need to be paused for several days, depending on the type.
Beyond medications, you should avoid caffeine on the day of the test since it has a mild bronchodilating effect that could mask your true airway reactivity. Smoking before the test can also skew results. Vigorous exercise on the day of testing is another variable to avoid, as it can temporarily change airway responsiveness. Your doctor’s office will give you specific instructions, and it’s important to follow them closely so the results are meaningful.
Side Effects and Recovery
Because the test intentionally triggers airway narrowing, you will likely feel some effects. Coughing, wheezing, chest tightness, and shortness of breath are common during the procedure. These sensations can be uncomfortable but are expected and closely monitored.
If your lung function drops by 20% or more at any point, the test stops and you’re given an inhaled bronchodilator (typically albuterol) to reopen your airways. Even if your result is negative, you may still receive a bronchodilator at the end to reverse any mild narrowing that occurred. You’ll repeat spirometry after treatment to confirm that your lung function has returned to baseline, and you won’t leave the testing area until it has. Most people feel completely normal within 15 to 30 minutes of receiving the bronchodilator.
Who Should and Shouldn’t Take the Test
The methacholine challenge is most useful when asthma is suspected but can’t be confirmed through standard spirometry or peak flow monitoring. This is common because many people with asthma have normal lung function between episodes. The test is also used in occupational health settings to determine whether workplace exposures are triggering asthma-like symptoms.
Certain people should not take the test. If your baseline FEV1 is already significantly reduced (typically below 60 to 70% of predicted), the test isn’t safe because further airway narrowing could be dangerous. People who have had a heart attack or stroke within the past three months, those with uncontrolled high blood pressure, and anyone with a known aortic aneurysm are also excluded. Pregnancy is another contraindication since the effects of methacholine-induced bronchoconstriction on the fetus aren’t well studied. A recent respiratory infection can temporarily increase airway reactivity, so most clinicians recommend waiting 4 to 6 weeks after a cold or upper respiratory illness before testing.